CD14 and endometrial cancer: However, CD62L on CD62L+ plasmacytoid Dendritic Cell (OR=0.831, 95%CI; 0.699-0.989, P=0.037) and CD14- CD16+ monocyte %monocyte (OR=0.465, 95%CI; 0.227-0.953, P=0.036) were negatively associated with the risk of endometrial cancer.